NovaBay Pharmaceuticals, Inc. (NBY) has 20 known insider and institutional holders on record. The largest holder is Pioneer Pharma (Hong Kong) Co Ltd with 5,188,421 shares. Other notable holders include Fu Jian Ping and Pioneer Pharma (Singapore) Pte. Ltd..
Over the last 12 months, insiders have made 15 transactions in NBY stock — 9 buys (valued at $81.08K) and 1 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
NBY Insider Ownership
Top Holder
Pioneer Pharma (Hong Kong) Co Ltd
5,188,421 shares
Buys (12 mo)
9
$81.08K value
Sells (12 mo)
1
$0.00 value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Pioneer Pharma (hong Kong) Co Ltd |
10 Percent Owner |
5,188,421 |
2019-06-13 |
|
| 2 |
Fu Jian Ping |
10 Percent Owner |
4,000,000 |
2020-08-04 |
|
| 3 |
Pioneer Pharma (singapore) Pte. Ltd. |
10 Percent Owner |
3,879,519 |
2016-09-26 |
|
| 4 |
R01 Fund Lp |
10 Percent Owner |
2,702,703 |
2025-11-03 |
|
| 5 |
Framework Ventures Iv L.p. |
10 Percent Owner |
2,702,703 |
2025-11-03 |
|
| 6 |
Kazley Michael John |
10 Percent Owner, Officer: Chief Executive Officer |
2,702,703 |
2025-11-03 |
|
| 7 |
Naqu Area Pioneer Pharma Co., Ltd. |
10 Percent Owner |
2,000,000 |
2012-11-20 |
|
| 8 |
Poplar Point Capital Partners Lp |
10 Percent Owner |
550,000 |
2025-04-15 |
|
| 9 |
Khosrovi Behzad |
SVP Product Development |
536,283 |
2013-01-14 |
|
| 10 |
Stroman David W. |
SVP, Ophthalmic Product Devt. |
474,834 |
2015-10-06 |
|
| 11 |
Mcgovern John Joseph |
Int Pres, CEO, CFO & Treasurer |
440,000 |
2018-10-11 |
|
| 12 |
China Pioneer Pharma Holdings Ltd |
10 Percent Owner |
426,984 |
2014-05-14 |
|
| 13 |
Cashion Charles |
Director |
377,156 |
2015-01-06 |
|
| 14 |
Paulson Thomas J |
CFO |
310,788 |
2017-01-26 |
|
| 15 |
Wicks Tony D.s. |
Director |
301,016 |
2015-01-06 |
|
| 16 |
Bley Keith R |
SVP Product Development |
258,120 |
2014-09-30 |
|
| 17 |
Anderson Mark Brian |
CSO |
242,000 |
2011-11-01 |
|
| 18 |
Dailley Anthony |
Director |
191,967 |
2014-03-21 |
|
| 19 |
Tufts Robert R. |
Director |
191,468 |
2014-01-31 |
|
| 20 |
Stuart Lewis J |
Chief Commercial Officer |
100,000 |
2018-01-08 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2025-10-21 |
Lazar David E. |
10 Percent Owner |
Option Exercise (Sell) |
39,925 |
- |
- |
| 2025-10-21 |
Kazley Michael John |
10 Percent Owner, Officer: Chief Executive Officer |
Conversion (Buy) |
56,806,080 |
- |
- |
| 2025-10-16 |
Kazley Michael John |
10 Percent Owner, Officer: Chief Executive Officer |
Informative Buy |
2,702,703 |
$0.01 |
$27.03K |
| 2025-10-21 |
Framework Ventures Iv L.p. |
10 Percent Owner |
Conversion (Buy) |
56,806,080 |
- |
- |
| 2025-10-16 |
Framework Ventures Iv L.p. |
10 Percent Owner |
Informative Buy |
2,702,703 |
$0.01 |
$27.03K |
| 2025-10-21 |
R01 Fund Lp |
10 Percent Owner |
Conversion (Buy) |
56,806,080 |
- |
- |
| 2025-10-16 |
R01 Fund Lp |
10 Percent Owner |
Informative Buy |
2,702,703 |
$0.01 |
$27.03K |
| 2025-10-16 |
Kazley Michael John |
10 Percent Owner, Officer: Chief Executive Officer |
RSU Award |
134,375 |
- |
- |
| 2025-10-16 |
Kazley Michael John |
10 Percent Owner, Officer: Chief Executive Officer |
Unknown |
1,164,117 |
- |
- |
| 2025-10-16 |
Framework Ventures Iv L.p. |
10 Percent Owner |
Other (Buy) |
134,375 |
- |
- |
| 2025-10-16 |
Framework Ventures Iv L.p. |
10 Percent Owner |
Unknown |
1,164,117 |
- |
- |
| 2025-10-16 |
R01 Fund Lp |
10 Percent Owner |
RSU Award |
134,375 |
- |
- |
| 2025-10-16 |
R01 Fund Lp |
10 Percent Owner |
Unknown |
1,164,117 |
- |
- |
| 2025-10-16 |
Lazar David E. |
10 Percent Owner |
Informative Sell |
441,325 |
- |
- |
| 2025-08-19 |
Lazar David E. |
10 Percent Owner, Officer: Chief Executive Officer |
Unknown |
- |
- |
- |
